The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Open accessAbstract
A large body of evidence, including longitudinal analyses of personality change, suggests that core personality traits are predominantly stable after age 30. To our knowledge, no study has demonstrated changes in personality in healthy adults after an experimentally manipulated discrete event. Intriguingly, double-blind controlled studies have shown that the classic hallucinogen psilocybin occasions personally and spiritually significant mystical experiences that predict long-term changes in behaviors, attitudes and values. In the present report we assessed the effect of psilocybin on changes in the five broad domains of personality - Neuroticism, Extroversion, Openness, Agreeableness, and Conscientiousness. Consistent with participant claims of hallucinogen-occasioned increases in aesthetic appreciation, imagination, and creativity, we found significant increases in Openness following a high-dose psilocybin session. In participants who had mystical experiences during their psilocybin session, Openness remained significantly higher than baseline more than 1 year after the session. The findings suggest a specific role for psilocybin and mystical-type experiences in adult personality change.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A unique and fascinating feature of psychedelics is that intake of one or a few doses is associated with long-lasting effects on behaviors, attitudes, mood, and personality in humans”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as MacLean et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the few recent studies that measured personality traits, psychedelics were linked to reductions in neuroticism and increases in openness and extraversion across both non-clinical and clinical populations (33, 34).”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Post-psychedelic decreases in neuroticism and increases in extroversion, and openness to experience have also been reported [60, 61]; however, these findings have been inconsistent across studies.”
From The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Post-psychedelic decreases in neuroticism and increases in extroversion, and openness to experience have also been reported [60, 61]; however, these findings have been inconsistent across studies.”
From The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been suggested by some studies that the intensity or quality of the psychedelic experience determines the treatment outcome (52–54).”
From Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees (2022) · cites this paper as [53]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it has been repeatedly found that psychedelic-induced mystical-type experiences and ego dissolution, the latter a phenomenon characterized by the reduction in self-referential awareness, disruption self-world boundaries, and increased feelings of unity with one’s surroundings (55), correlates with long-term (positive) outcomes (23, 52–54, 56–58).”
From Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees (2022) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another potential selection bias remains, as studies including treatments with psychedelic substances require a rather high degree of motivation and openness to experience (82) by the participants because of the time-demanding study procedure and the phenomenologically rich nature of psychedelic experiences. This might have contributed to a ceiling effect regarding potential changes in trait”
From Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects (2024) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Supporting the view that the psychedelic experience is required for their therapeutic effects, participants who have so-called mystical experiences during psilocybin sessions score significantly higher compared with baseline on the personality trait Openness, and the change is correlated to the intensity of the experience (MacLean et al., 2011).”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as MacLean et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Studies using the five-factor model of personality suggest that psilocybin increases openness in healthy participants (34)”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [34]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Mindfulness meditation has been generally deemed safe, but numerous reports exist of acute and long-term negative effects associated with the practise (74, 165–167).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [74]
Experimental — accuracy not yet measuredIn the citing paper
“While it has repeatedly been shown that hallucinogens increase the personality trait openness (85, 86), experimental studies investigating the long-term effects of entactogens and hallucinogens on social cognition and behavior remain scarce.”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Personality Structure: Emergence Of The 5-Factor Model
Digman, J. M. (1990) · Annual Review of Psychology · doi:10.1146/annurev.ps.41.020190.002221 · Cited by 6,731
Personality trait structure as a human universal.
McCrae, R. R., & Costa, P. T. (1997) · American Psychologist · doi:10.1037/0003-066x.52.5.509 · Cited by 4,234
On the practice of dichotomization of quantitative variables.
MacCallum, R. C., Zhang, S., Preacher, K. J., & Rucker, D. D. (2002) · Psychological Methods · doi:10.1037/1082-989x.7.1.19 · Cited by 3,538 · cited 1×
“First, median split analyses have been associated with reductions of power and effect size (MacCallum et al., 2002).”
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · cited 9×
“Finally, designating participants who met the criteria for a complete mystical experience allowed a comparison with previous studies (Griffiths et al., 2008; Griffiths et al., 2006; Pahnke, 1963; Richards et al., 1977; Griffiths et al., 2011).”
InfluentialSelf-citationSources of human psychological differences: the Minnesota Study of Twins Reared Apart
Bouchard, T. J., Lykken, D. T., McGue, M., Segal, N. L., & Tellegen, A. (1990) · Science · doi:10.1126/science.2218526 · Cited by 1,373 · cited 1×
“Many studies have confirmed that these personality factors are heritable (Bouchard et al., 1990) and reliable across cultures, suggesting a universal human personality structure that is rooted in biology (McCrae and Costa, 1997).”
What Do We Know When We Know a Person?
McAdams, D. P. (1995) · Journal of Personality · doi:10.1111/j.1467-6494.1995.tb00500.x · Cited by 1,235
Personality Trait Change in Adulthood
Roberts, B. W., & Mroczek, D. (2008) · Current Directions in Psychological Science · doi:10.1111/j.1467-8721.2008.00543.x · Cited by 1,222
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206
Human hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
Self-citation
Research works printed but not linked: 5
- Costa PT, 1992, Revised NEO Personality Inventory (NEO-PI-R) and NEO Five Factor Inventory (NEO-FFI) Professional Manual
- Doblin R, 1991, J Transpers Psychol, 23, 1
- Metzner R, 1963, Psychedel Rev, 1, 18
- Pahnke WN (1963) Drugs and mysticism: an analysis of the relationship between psychedelic drugs and the mystical consciousness. Thesis. Harvard University, Boston.
- Unger SM, 1964, LSD: The Consciousness-expanding Drug, 200
Cited by
Sorted by citations
Items 101–130 of 130
Luoma, J. B., Sabucedo, P., Eriksson, J., Gates, N., & Pilecki, B. C. (2019) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.10.003 · Cited by 56
Skosnik, P. D., Sloshower, J., Safi-Aghdam, H., Pathania, S., Syed, S., Pittman, B., & D’Souza, D. C. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231179800 · Cited by 51
Stressful life events and openness to experience: Relevance to depression
Chiappelli, J., Kvarta, M., Bruce, H., Chen, S., Kochunov, P., & Hong, L. E. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.112 · Cited by 48
Weiss, B., Nygart, V., Pommerencke, L. M., Carhart-Harris, R. L., & Erritzoe, D. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.749788 · Cited by 47
Studies with psychedelic drugs in human volunteers
Sellers, E. M., Romach, M. K., & Leiderman, D. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.029 · Cited by 42
Eleftheriou, M. E., & Thomas, E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.707057 · Cited by 39
“These occurrences are usually extremely rare and profoundly personally meaningful, and often lead to longlasting transformations in psychology and behaviour (28, 74, 75).”
BackgroundOrłowski, P., Ruban, A., Szczypiński, J., Hobot, J., Bielecki, M., & Bola, M. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221089034 · Cited by 41
Lafrance, A., Strahan, E., Bird, B. M., St. Pierre, M., & Walsh, Z. (2021) · Journal of Humanistic Psychology · doi:10.1177/00221678211048049 · Cited by 40
Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action
Rieser, N. M., Herdener, M., & Preller, K. H. (2021) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2021_284 · Cited by 37
Fernández, X., dos Santos, R. G., Cutchet, M., Fondevila, S., González, D., Alcázar, M. Á., Riba, J., Bouso, J. C., & María Fábregas, J. (2014) · The Therapeutic Use of Ayahuasca · doi:10.1007/978-3-642-40426-9_11 · Cited by 36
Pepe, M., Hesami, M., de la Cerda, K. A., Perreault, M. L., Hsiang, T., & Jones, A. M. P. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108247 · Cited by 36
Aicher, H. D., Mueller, M. J., Dornbierer, D. A., Suay, D., Elsner, C., Wicki, I., Meling, D., Caflisch, L., Hempe, A., Steinhart, C., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1302559 · Cited by 33
“…selection bias remains, as studies including treatments with psychedelic substances require a rather high degree of motivation and openness to experience (82) by the participants because of the time-demanding study procedure and the phenomenologically rich nature of psychedelic experiences.”
BackgroundFrymann, T., Whitney, S., Yaden, D. B., & Lipson, J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.863247 · Cited by 30
Pagni, B. A., Zeifman, R. J., Mennenga, S. E., Carrithers, B. M., Goldway, N., Bhatt, S., O’Donnell, K. C., Ross, S., & Bogenschutz, M. P. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230887 · Cited by 31
Toward specific ways to combine ketamine and psychotherapy in treating depression
Hasler, G. (2020) · CNS Spectrums · doi:10.1017/s1092852919001007 · Cited by 29
DellaCrosse, M., Pleet, M., Morton, E., Ashtari, A., Sakai, K., Woolley, J., & Michalak, E. (2022) · PLOS ONE · doi:10.1371/journal.pone.0279073 · Cited by 28
Johnstad, P. G. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1842569 · Cited by 29
Kiraga, M. K., Kuypers, K. P. C., Uthaug, M. V., Ramaekers, J. G., & Mason, N. L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.883869 · Cited by 26
“Specifically, it has been repeatedly found that psychedelic-induced mystical-type experiences and ego dissolution, the latter a phenomenon characterized by the reduction in selfreferential awareness, disruption self-world boundaries, and increased feelings of unity with one’s surroundings (Nour and Carhart-Harris 2017…”
BackgroundO'Donnell, K. C., Mennenga, S. E., Owens, L. T., Podrebarac, S. K., Baron, T., Rotrosen, J., Ross, S., Forcehimes, A. A., & Bogenschutz, M. P. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106976 · Cited by 23
Davis, A. K., Levin, A. W., Nagib, P. B., Armstrong, S. B., & Lancelotta, R. L. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068884 · Cited by 21
Naturalizing psychedelic spirituality
Letheby, C. (2017) · Zygon: Journal of Religion and Science · doi:10.1111/zygo.12353 · Cited by 18
Bright, S., Gringart, E., Blatchford, E., & Bettinson, S. (2021) · Australian Journal of Psychology · doi:10.1080/00049530.2021.1882266 · Cited by 16
“Openness is one of the Big Five personality factors, which refers to broadminded tolerance of others’ values and viewpoints, aesthetic appreciation, sensitivity, imagination, and fantasy (MacLean et al., 2011).”
Dressler, H. M., Bright, S. J., & Polito, V. (2021) · Journal of Psychedelic Studies · doi:10.1556/2054.2021.00157 · Cited by 14
Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study
Hartong, V., & van Emmerik, A. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2080616 · Cited by 11
“…al. 2011; Ross et al. 2016) and may include changes in relatively stable traits such as openness and neuroticism (Dressler, Bright, and Polito 2021; MacLean, Johnson, and Griffiths 2011) and mindfulness (Madsen et al. 2020; Soler et al. 2016; Uthaug et al. 2019), the second aim of this study was…”
BackgroundSt. Arnaud, K. O., & Cormier, D. C. (2017) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2017.36.2.44 · Cited by 12
Johansen, L., Liknaitzky, P., Nedeljkovic, M., Mastin-Purcell, L., & Murray, G. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01930-7 · Cited by 11
“Post-psychedelic decreases in neuroticism and increases in extroversion, and openness to experience have also been reported [60, 61]; however, these findings have been inconsistent across studies.”
ResultChing, T. H. W., Grazioplene, R., Pittenger, C., & Kelmendi, B. (2023) · doi:10.31234/osf.io/ba42z · Cited by 6
Albert, A. E., & Back, A. L. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1529427 · Cited by 6
Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness
Studerus, E. (2012) · University of Zurich · doi:10.5167/uzh-164092 · Cited by 6
Could psychedelics treat personality disorders
(2022) · Journal of Addiction Science · doi:10.17756/jas.2022-057 · Cited by 3
Metadata
- Authors
- MacLean, K. A., Johnson, M. W., & Griffiths, R. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- MacLean, Katherine A
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2011-09-28
- Volume
- 25
- Issue
- 11
- Pages
- 1453-1461
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC3537171
- OpenAlex
- W2118739111
- Cited by
- 895
- References
- 56
- Citations by year
- 2026: 48 · 2025: 80 · 2024: 92 · 2023: 87 · 2022: 93 · 2021: 100 · 2020: 100 · 2019: 63 · 2018: 56 · 2017: 50 · 2016: 46 · 2015: 23 · 2014: 22 · 2013: 15 · 2012: 17
- FWCI
- 18.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA003889, T32DA007209, R01DA03889)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psilocybin, mystical experience, personality change, openness to experience, personality traits, hallucinogens, Big Five personality traits, aesthetic appreciation
- MeSH terms
- Adult, Attitude, Behavior, Double-Blind Method, Extraversion, Psychological, Female, Follow-Up Studies, Hallucinogens, Humans, Longitudinal Studies, Male, Middle Aged, Mysticism, Personality, Psilocybin, Randomized Controlled Trials as Topic, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
